Healthcare provider profile · identity verified

Ezra Lyon, M.D.

Family Practice · WAUSAU, WI · NPI 1669906004

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	403	118
Atorvastatin Calcium	Atorvastatin Calcium	399	116
Amlodipine Besylate	Amlodipine Besylate	308	101
Rosuvastatin Calcium	Rosuvastatin Calcium	280	85
Metoprolol Succinate	Metoprolol Succinate	265	81
Levothyroxine Sodium	Levothyroxine Sodium	206	51
Hydrochlorothiazide	Hydrochlorothiazide	180	58
Losartan Potassium	Losartan Potassium	167	54
Eliquis	Apixaban	134	37
Tamsulosin Hcl	Tamsulosin Hcl	127	43
Potassium Chloride	Potassium Chloride	120	37
Omeprazole	Omeprazole	119	40
Metformin Hcl Er	Metformin Hcl	113	33
Simvastatin	Simvastatin	111	35
Pantoprazole Sodium	Pantoprazole Sodium	110	30
Furosemide	Furosemide	109	41
Duloxetine Hcl	Duloxetine Hcl	108	30
Metoprolol Tartrate	Metoprolol Tartrate	101	32
Metformin Hcl	Metformin Hcl	93	31
Allopurinol	Allopurinol	92	24
Jardiance	Empagliflozin	92	19
Albuterol Sulfate Hfa	Albuterol Sulfate	87	38
Gabapentin	Gabapentin	87	31
Clonazepam	Clonazepam	79	suppressed
Sertraline Hcl	Sertraline Hcl	72	20
Pravastatin Sodium	Pravastatin Sodium	69	25
Spironolactone	Spironolactone	69	19
Alprazolam	Alprazolam	67	suppressed
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Fluticasone Propionate	Fluticasone Propionate	63	27
Meloxicam	Meloxicam	60	17
Warfarin Sodium	Warfarin Sodium	59	13
Carvedilol	Carvedilol	57	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	15
Trazodone Hcl	Trazodone Hcl	52	15
Ezetimibe	Ezetimibe	51	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Clopidogrel	Clopidogrel Bisulfate	47	20
Pregabalin	Pregabalin	46	suppressed
Alendronate Sodium	Alendronate Sodium	40	13
Triamcinolone Acetonide	Triamcinolone Acetonide	40	15
Bumetanide	Bumetanide	39	suppressed
Famotidine	Famotidine	39	11
Fosinopril Sodium	Fosinopril Sodium	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	36	suppressed
Lorazepam	Lorazepam	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Prednisone	Prednisone	33	14
Hydroxyzine Hcl	Hydroxyzine Hcl	32	13
Montelukast Sodium	Montelukast Sodium	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	31	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Finasteride	Finasteride	28	11
Ozempic	Semaglutide	28	suppressed
Valsartan	Valsartan	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Estradiol	Estradiol	26	suppressed
Methadone Hcl	Methadone Hcl	26	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Cephalexin	Cephalexin	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Digoxin	Digoxin	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Buprenorphine	Buprenorphine	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Glipizide	Glipizide	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Naloxone Hcl	Naloxone Hcl	15	14
Naproxen	Naproxen	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Topiramate	Topiramate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diazepam	Diazepam	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Primidone	Primidone	11	suppressed
Sublocade	Buprenorphine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error